Cited by 61Nutritional Studies and DietDiabetes Treatment and ManagementDiet and metabolism studies

The effect of macronutrients on glycaemic control: a systematic review of dietary randomised controlled trials in overweight and obese adults with type 2 diabetes in which there was no difference in weight loss between treatment groups

Open access
Emadian, Amir, Andrews, Rob C., England, Clare Y., Wallace, Victoria, Thompson, Janice L.·2015·British Journal of Nutrition

Abstract

Weight loss is crucial for treating type 2 diabetes mellitus (T2DM). It remains unclear which dietary intervention is best for optimising glycaemic control, or whether weight loss itself is the main reason behind observed improvements. The objective of this study was to assess the effects of various dietary interventions on glycaemic control in overweight and obese adults with T2DM when controlling for weight loss between dietary interventions. A systematic review of randomised controlled trials (RCT) was conducted. Electronic searches of Medline, Embase, Cinahl and Web of Science databases were conducted. Inclusion criteria included RCT with minimum 6 months duration, with participants having BMI≥25·0 kg/m 2, a diagnosis of T2DM using HbA1c, and no statistically significant difference in mean weight loss at the end point of intervention between dietary arms. Results showed that eleven studies met the inclusion criteria. Only four RCT indicated the benefit of a particular dietary intervention over another in improving HbA1c levels, including the Mediterranean, vegan and low glycaemic index (GI) diets. However the findings from one of the four studies showing a significant benefit are questionable because of failure to control for diabetes medications and poor adherence to the prescribed diets. In conclusion there is currently insufficient evidence to suggest that any particular diet is superior in treating overweight and obese patients with T2DM. Although the Mediterranean, vegan and low-GI diets appear to be promising, further research that controls for weight loss and the effects of diabetes medications in larger samples is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0007114515003475

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The association between the use of GLP-1 receptor agonists and the risk of acute pancreatitis is negative.

    “The association between the use of GLP‐1 receptor agonists and the risk of acute pancreatitis has been shown to be negative 25 , 26 , 27 , 28 , 29 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [26]

  • The use of fibrates reduces the risk of non-fatal cardiovascular disease in patients with diabetes and dyslipidemia.

    “The use of fibrates has been shown to reduce the risk of non‐fatal CVD in patients with diabetes and dyslipidemia 24 , 25 , 26 , 27 , 28 (grade B: 88% agreement).”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [26]

  • Coffee or tea intake is a preventive factor against type 2 diabetes.

    “Coffee or tea intake is shown to be a preventive factor against type 2 diabetes 26 , 27 .”

    From Japanese clinical practice guideline for diabetes 2019 (2020) · cites this paper as [26]

  • No single eating plan approach has been proven to be consistently superior for weight loss in people with diabetes.

    “However, no single approach has been proven to be consistently superior (70,(123)(124)(125), and more data are needed to identify and validate those meal plans that are optimal with respect to long-term outcomes and acceptability.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Emadian, A., Andrews, R. C., England, C. Y., Wallace, V., & Thompson, J. L.
Affiliations
  • University of Birmingham (GB)
  • University of Bristol (GB)
Corresponding author
Emadian, Amir
Venue
British Journal of Nutrition
Published
2015-09-28
Volume
114
Issue
10
Pages
1656-1666
ISSN
  • 0007-1145 (ISSN-L)
  • 1475-2662
OpenAlex
W2120418386
Cited by
61
References
23
Citations by year
2025: 3 · 2024: 6 · 2023: 11 · 2022: 7 · 2021: 7 · 2020: 7 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 2 · 2015: 1
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • British Journal Of Nutrition (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion, cc-by)
  • Explore Bristol Research (submittedVersion, cc-by)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
Funders
  • National Institute for Health and Care Research (CAT CDRF 10-017)
  • University of Cambridge
  • Medical Research Council (MR/K00414X/1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Physiology › Diet and metabolism studies
Keywords
type 2 diabetes, glycemic control, macronutrients, dietary intervention, Mediterranean diet, vegan diet, low glycemic index diet, weight loss, overweight, obesity, HbA1c, antidiabetic drugs, dietary adherence
MeSH terms
Diet, Vegan, Blood Glucose, Diabetes Mellitus, Type 2, Diet, Glycated Hemoglobin, Humans, Obesity, Weight Loss, Randomized Controlled Trials as Topic, MEDLINE, Glycemic Index, Diet, Mediterranean, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review